Inventor · disambiguated record
Carlos J. Carrera
Also filed as: CARRERA CARLOS J
8 granted patents·2 pending applications·328 citations·filing 1990–2003
90Inventor score
Top patents by PatentIndex Score
10 records- 0190US5310732A2-halo-2'-deoxyadenosines in the treatment of rheumatoid arthritisSCRIPPS RESEARCH INST·Filed 1992·Granted May 10, 1994·65 cites·5 claims
- 0284US6576420B1Method for early diagnosis of, and determination of prognosis in, cancerUNIV CALIFORNIA·Filed 1999·Granted Jun 10, 2003·111 cites·27 claims
- 0383US5106837AAdenosine derivatives with therapeutic activitySCRIPPS RESEARCH INST·Filed 1990·Granted Apr 21, 1992·58 cites·4 claims
- 0480US5506213AAdminstration of 2'-halo-2'-deoxy adenosine to treat inflammatory bowel diseaseSCRIPPS RESEARCH INST·Filed 1994·Granted Apr 9, 1996·29 cites·10 claims
- 0577US5541164A2-halo-2'-deoxyadenosines in the treatment of monocyte-mediated inflammatory disease conditionsSCRIPPS RESEARCH INST·Filed 1994·Granted Jul 30, 1996·24 cites·9 claims
- 0662US6210917B1Method for suppressing multiple drug resistance in cancer cellsUNIV CALIFORNIA·Filed 1997·Granted Apr 3, 2001·22 cites·12 claims
- 0759US5840505AMethod for inhibiting adenylosuccinate synthetase activity in methylthioadenosine phosphorylase deficient cellsUNIV CALIFORNIA·Filed 1996·Granted Nov 24, 1998·11 cites·13 claims
- 0856US2003175768A1Method for early diagnosis of, and determination of prognosis in, cancerUNIV CALIFORNIA·Filed 2002·Application pending·0 cites
- 0953US2004096436A1Methods for inhibiting protein kinases in cancer cellsUNIV CALIFORNIA·Filed 2003·Application pending·0 cites
- 1051US6214571B1Method for inhibiting adenylosuccinate synthetase activity in malignant methylthioadenosine phosphorylase deficient cellsUNIV CALIFORNIA·Filed 1998·Granted Apr 10, 2001·8 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Carlos J. Carrera files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →